Repositrak, Inc. (TRAK) - 10-K Summary
Business Context and Reporting Period
Company: ReposiTrak, Inc.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal Year Ended June 30, 2025
Business Overview: ReposiTrak is a Software-as-a-Service (SaaS) provider operating a B2B e-commerce, compliance, traceability, and supply chain management platform. The company serves retailers, wholesalers, and distributors, primarily in the food and convenience store sectors. Its core solutions include Compliance Management, the ReposiTrak Traceability Network (RTN) for FDA FSMA 204 compliance, and Supply Chain Solutions.
Key Financial Metrics
| Metric | Fiscal 2025 | Fiscal 2024 |
|---|---|---|
| Revenue | $22,606,066 | $20,453,320 |
| Net Income | $6,978,127 | $5,958,290 |
| Net Income (Common Shareholders) | $6,617,821 | $5,408,645 |
| Operating Cash Flow | $8,420,132 | $6,964,401 |
| Cash and Equivalents (End of Period) | $28,568,805 | $25,153,862 |
| Working Capital | $28,154,682 | $24,757,025 |
| Current Ratio | 6.09 | 6.45 |
| Bank Debt | $0 | $0 |
| Basic EPS | $0.36 | $0.30 |
| Diluted EPS | $0.35 | $0.29 |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 11% to $22.6 million, driven by growth in recurring subscription revenue across compliance, supply chain, and traceability lines.
- Profitability: Net income increased 17% to $6.98 million. Operating income rose to $6.23 million.
- Expense Trends:
- Cost of Services: Increased 8% to $3.68 million (16% of revenue) due to cybersecurity spending and offshore developer support for FSMA 204 initiatives.
- Sales & Marketing: Increased 6% to $5.84 million (26% of revenue) due to higher commissions and traceability marketing.
- General & Administrative: Increased 5% to $5.60 million (25% of revenue) due to salary increases, stock compensation, and bad debt expense.
- Debt and Liquidity: The company terminated its $10 million revolving credit facility in March 2024 and currently holds zero bank debt. Cash balances increased 14% year-over-year.
- Preferred Stock: The company redeemed 280,372 shares of Series B Preferred Stock during the fiscal year. Series B-1 Preferred was fully redeemed and the designation withdrawn in December 2024.
Guidance, Outlook, and Risks
- Dividend Policy: The Board declared a quarterly cash dividend of $0.01815 per share for Q4 2025. A 10% increase to $0.02 per share ($0.08 annually) was announced for the quarter ending September 30, 2025.
- Regulatory Outlook: The FDA extended the FSMA 204 compliance deadline to July 20, 2028. While this may slow immediate adoption, major retailers are implementing stricter traceability requirements ahead of the federal deadline, driving demand for ReposiTrak's solutions.
- Capital Allocation: The company intends to redeem remaining Series B Preferred Stock (approx. $3.2 million obligation) by December 2026. A share repurchase program remains active with $7.79 million available.
- Risk Factors:
- Key Person Risk: Operations are heavily dependent on CEO Randall K. Fields.
- Regulatory Delays: Further delays in FSMA 204 enforcement could reduce customer urgency to purchase compliance software.
- Competition: Larger competitors with greater resources may offer better pricing or superior technology.
- Cybersecurity: As a data-heavy SaaS provider, security breaches could materially harm reputation and operations.
Investor Verification Checklist
- FSMA 204 Impact: Verify the actual conversion rate of traceability leads to paid subscriptions given the extended regulatory deadline.
- Customer Concentration: Confirm that no single customer exceeds 10% of revenue (stated as true for FY2025) and review the aging of the $962k receivable from the largest customer.
- Preferred Stock Redemption: Monitor cash outflows related to the remaining $3.2 million Series B Preferred redemption obligation.
- Dividend Sustainability: Assess if the increased dividend rate ($0.02/share) is sustainable given the company's capital expenditure plans and preferred stock buybacks.
- Bad Debt Provision: Review the $600,000 bad debt expense recorded in FY2025 to ensure it reflects current economic conditions and customer creditworthiness.